Cintas
CTAS
223.07
-3.34
-1.47%
Cintas
US · CTAS
#282 by market cap
Listed 1970
223.07
-3.34
-1.47%
Periodic snapshot; not a real-time feed.
· 2026-11-06 15:00
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 28 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.5 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 69.54% +0.50pp
- Institutions
- 1,738 +28
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund57.02%
Individual/Insider14.52%
Public Company3.02%
Hedge Fund2.97%
Private Company1.77%
Government Pension Fund1.52%
Insurance Company1.23%
Sovereign Wealth Fund1.14%
Corporate Pension Plan0.42%
Other16.39%
Top holders as of 2026-08-31
Scott Farmer
14.11% · 56.04M sh
BlackRock
6.69% · 26.58M sh
Vanguard Capital Management, LLC
6.09% · 24.16M sh
State Street Global Advisors
3.98% · 15.82M sh
Vanguard Portfolio Management, LLC
3.39% · 13.45M sh
Other
66.05%
Invesco Capital Management LLC
3.28% · 13.04M sh
Geode Capital Management, LLC
2.40% · 9.55M sh
T. Rowe Price Group, Inc.
1.45% · 5.76M sh
FMR
1.12% · 4.44M sh
Norges Bank Investment Management
1.10% · 4.36M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 37 buys · 13 sells
| Name | Role | Stake |
|---|---|---|
| Scott Farmer | Executive Chairperson | 14.11% |
| Todd Schneider | Chief Executive Officer | 0.18% |
| Robert Coletti | Director | 0.09% |
| James Rozakis | President | 0.07% |
| Scott Garula | Chief Financial Officer | 0.03% |
| Joseph Scaminace | Lead Independent Director | 0.01% |
| J. Hansen | Chief Financial Officer | 0.01% |
| David Denton | General Counsel | 0.01% |
| Melanie Barstad | Independent Director | 0.01% |
| Karen Carnahan | Independent Director | 0.01% |
| Ronald Tysoe | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-14 | Karen Carnahan | Independent Director | Other Derivative Acquisition | +17 | -- |
| 2026-09-14 | Ronald Tysoe | Independent Director | Other Derivative Acquisition | +101 | -- |
| 2026-09-14 | Melanie Barstad | Former Independent Director | Other Derivative Acquisition | +12 | -- |
| 2026-09-14 | Robert Coletti | Director | Other Derivative Acquisition | +29 | -- |
| 2026-08-09 | Scott Farmer | Executive Chairperson | Sale to Issuer | -15,923 | $202.71 |
| 2026-08-09 | Scott Farmer | Executive Chairperson | Other Acquisition | +830 | $202.71 |
| 2026-08-09 | David Denton | General Counsel | Sale to Issuer | -3,479 | $202.71 |
| 2026-08-09 | David Denton | General Counsel | Other Acquisition | +5,718 | $202.71 |
| 2026-08-09 | David Denton | General Counsel | Other Derivative Acquisition | +22,434 | $202.71 |
| 2026-08-09 | Todd Schneider | Chief Executive Officer | Sale to Issuer | -35,599 | $202.71 |
| 2026-08-09 | Todd Schneider | Chief Executive Officer | Other Acquisition | +57,944 | $202.71 |
| 2026-08-09 | Scott Garula | Chief Financial Officer | Sale to Issuer | -2,958 | $202.71 |
| 2026-08-09 | Scott Garula | Chief Financial Officer | Other Acquisition | +10,695 | $202.71 |
| 2026-08-09 | James Rozakis | President | Sale to Issuer | -4,041 | $202.71 |
| 2026-08-09 | James Rozakis | President | Other Acquisition | +11,250 | $202.71 |
| 2026-08-09 | James Rozakis | President | Other Derivative Acquisition | +41,983 | $202.71 |
| 2026-07-27 | Karen Carnahan | Independent Director | Other Derivative Acquisition | +133 | -- |
| 2026-07-27 | Melanie Barstad | Former Independent Director | Other Derivative Acquisition | +148 | -- |
| 2026-07-27 | Robert Coletti | Director | Other Derivative Acquisition | +116 | -- |
| 2026-07-21 | Ronald Tysoe | Independent Director | Derivative Exercise and Sale | -5,048 | $27.10–199.90 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-06 15:00:09 · For reference only, not investment advice and not tailored to your situation.
Cintas discussion 0 comments